BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17878389)

  • 1. Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus.
    Yasuda S; Stevens RL; Terada T; Takeda M; Hashimoto T; Fukae J; Horita T; Kataoka H; Atsumi T; Koike T
    J Immunol; 2007 Oct; 179(7):4890-900. PubMed ID: 17878389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
    Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
    Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Characterization of
    Molineros JE; Singh B; Terao C; Okada Y; Kaplan J; McDaniel B; Akizuki S; Sun C; Webb CF; Looger LL; Nath SK
    Front Immunol; 2019; 10():1066. PubMed ID: 31164884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus.
    Rapoport MJ; Bloch O; Amit-Vasina M; Yona E; Molad Y
    Lupus; 2011 Dec; 20(14):1501-9. PubMed ID: 21976405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity.
    Baars MJD; Douma T; Simeonov DR; Myers DR; Kulhanek K; Banerjee S; Zwakenberg S; Baltissen MP; Amini M; de Roock S; van Wijk F; Vermeulen M; Marson A; Roose JP; Vercoulen Y
    Eur J Immunol; 2021 Feb; 51(2):471-482. PubMed ID: 33065764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the C/EBP β LAP isoform could be due to decreased TNFAIP3/TNIP1 expression in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
    Qian T; Chen F; Shi X; Li J; Li M; Chen Y; Hao F; Zhang D
    Mod Rheumatol; 2017 Jul; 27(4):657-663. PubMed ID: 27659348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Lupus Erythematosus Patients Exhibit Reduced Expression of CLEC16A Isoforms in Peripheral Leukocytes.
    Tam RC; Lee AL; Yang W; Lau CS; Chan VS
    Int J Mol Sci; 2015 Jun; 16(7):14428-40. PubMed ID: 26121298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.
    Roose JP; Mollenauer M; Gupta VA; Stone J; Weiss A
    Mol Cell Biol; 2005 Jun; 25(11):4426-41. PubMed ID: 15899849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Kammer GM; Tsokos GC
    J Autoimmun; 2001 Mar; 16(2):133-42. PubMed ID: 11247639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple checkpoint breach of B cell tolerance in Rasgrp1-deficient mice.
    Bartlett A; Buhlmann JE; Stone J; Lim B; Barrington RA
    J Immunol; 2013 Oct; 191(7):3605-13. PubMed ID: 23997211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis.
    Hashimoto T; Yasuda S; Koide H; Kataoka H; Horita T; Atsumi T; Koike T
    Arthritis Res Ther; 2011; 13(5):R154. PubMed ID: 21933395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
    Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
    J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.
    Roose JP; Mollenauer M; Ho M; Kurosaki T; Weiss A
    Mol Cell Biol; 2007 Apr; 27(7):2732-45. PubMed ID: 17283063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity.
    Yi W; Gupta S; Ricker E; Manni M; Jessberger R; Chinenov Y; Molina H; Pernis AB
    Nat Commun; 2017 Aug; 8(1):254. PubMed ID: 28811467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors.
    Golinski ML; Vandhuick T; Derambure C; Fréret M; Lecuyer M; Guillou C; Hiron M; Boyer O; Le Loët X; Vittecoq O; Lequerré T
    Arthritis Res Ther; 2015 Dec; 17():382. PubMed ID: 26714738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.